Feasibility and suitability of a graded exercise test in patients with aggressive hemato-oncological disease.


Journal

Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer
ISSN: 1433-7339
Titre abrégé: Support Care Cancer
Pays: Germany
ID NLM: 9302957

Informations de publication

Date de publication:
Aug 2021
Historique:
received: 28 09 2020
accepted: 28 01 2021
pubmed: 6 2 2021
medline: 24 7 2021
entrez: 5 2 2021
Statut: ppublish

Résumé

Physical activity promises to reduce disease-related symptoms and therapy-related side effects in patients suffering from aggressive lymphoma (L) or acute leukemia (AL). For an efficient training program, determination of patients' physical capacity with a purposive exercise test is crucial. Here, we evaluated the feasibility and suitability of a graded exercise test (GXT) frequently applied in patients suffering from solid tumors by assessing whether patients achieved criteria for maximal exercise testing according to the American College of Sports Medicine (ACSM). The GXT was performed by 51 patients with an aggressive L or AL prior to the start or in the earliest possible phase of high-dose chemotherapy, following a recommended protocol for cancer patients, starting at 20 Watts (W), with an increase of 10 W/min until volitional exhaustion. Subsequently, we investigated whether the following ACSM criteria were fulfilled: (1) failure of heart rate to increase despite increasing workload, (2) post-exercise capillary lactate concentration ≥ 8.0 mmol L Out of 51 patients, two, six, and 35 participants met the first, second, and third criterion, respectively. No relevant relationships between the completion of the criteria and patients' characteristics (e.g., gender, age) were found. Although results of this study suggest a general feasibility of the applied GXT, the ACSM criteria were not met by the majority of the participants. Therefore, this study raises doubts about the suitability of the GXT protocol and the ACSM criteria for this group of patients.

Identifiants

pubmed: 33544247
doi: 10.1007/s00520-021-06035-w
pii: 10.1007/s00520-021-06035-w
pmc: PMC8236443
doi:

Types de publication

Journal Article Randomized Controlled Trial

Langues

eng

Sous-ensembles de citation

IM

Pagination

4859-4866

Références

Robert-Koch-Institut (2019) Krebs in Deutschland für 2015 / 2016. https://doi.org/10.25646/5977
Deschler B, Ihorst G, Platzbecker U, Germing U, Marz E, de Figuerido M, Fritzsche K, Haas P, Salih HR, Giagounidis A, Selleslag D, Labar B, de Witte T, Wijermans P, Lubbert M (2013) Parameters detected by geriatric and quality of life assessment in 195 older patients with myelodysplastic syndromes and acute myeloid leukemia are highly predictive for outcome. Haematologica 98:208–216. https://doi.org/10.3324/haematol.2012.067892
doi: 10.3324/haematol.2012.067892 pubmed: 22875615 pmcid: 3561427
Redaelli A, Stephens JM, Brandt S, Botteman MF, Pashos CL (2004) Short- and long-term effects of acute myeloid leukemia on patient health-related quality of life. Cancer Treat Rev 30:103–117. https://doi.org/10.1016/S0305-7372(03)00142-7
doi: 10.1016/S0305-7372(03)00142-7 pubmed: 14766128
Bryant AL, Deal AM, Battaglini CL, Phillips B, Pergolotti M, Coffman E, Foster MC, Wood WA, Bailey C, Hackney AC, Mayer DK, Muss HB, Reeve BB (2018) The effects of exercise on patient-reported outcomes and performance-based physical function in adults with acute leukemia undergoing induction therapy: Exercise and Quality of Life in Acute Leukemia (EQUAL). Integr Cancer Ther 17:263–270. https://doi.org/10.1177/1534735417699881
doi: 10.1177/1534735417699881 pubmed: 28627275
Schumacher A, Wewers D, Heinecke A, Sauerland C, Koch OM, van de Loo J, Büchner T, Berdel WE (2002) Fatigue as an important aspect of quality of life in patients with acute myeloid leukemia. Leuk Res 26:355–362. https://doi.org/10.1016/s0145-2126(01)00145-x
doi: 10.1016/s0145-2126(01)00145-x pubmed: 11839378
Schmitz KH, Campbell AM, Stuiver MM, Pinto BM, Schwartz AL, Morris GS, Ligibel JA, Cheville A, Galvão DA, Alfano CM, Patel AV, Hue T, Gerber LH, Sallis R, Gusani NJ, Stout NL, Chan L, Flowers F, Doyle C, Helmrich S, Bain W, Sokolof J, Winters-Stone KM, Campbell KL, Matthews CE (2019) Exercise is medicine in oncology: engaging clinicians to help patients move through cancer. CA Cancer J Clin 69:468–484. https://doi.org/10.3322/caac.21579
doi: 10.3322/caac.21579 pubmed: 31617590 pmcid: 7896280
Hayes SC, Spence RR, Galvão DA, Newton RU (2009) Australian Association for Exercise and Sport Science position stand: optimising cancer outcomes through exercise. J Sci Med Sport 12:428–434. https://doi.org/10.1016/j.jsams.2009.03.002
doi: 10.1016/j.jsams.2009.03.002 pubmed: 19428291
Schmitz KH, Courneya KS, Matthews C, Demark-Wahnefried W, Galvão DA, Pinto BM, Irwin ML, Wolin KY, Segal RJ, Lucia A, Schneider CM, von Gruenigen V, Schwartz AL, American College of Sports Medicine (2010) American College of Sports Medicine roundtable on exercise guidelines for cancer survivors. Med Sci Sports Exerc 42:1409–1426. https://doi.org/10.1249/MSS.0b013e3181e0c112
doi: 10.1249/MSS.0b013e3181e0c112 pubmed: 20559064
Barisic A, Leatherdale ST, Kreiger N (2011) Importance of frequency, intensity, time and type (FITT) in physical activity assessment for epidemiological research. Can J Public Health 102:174–175. https://doi.org/10.1007/BF03404889
doi: 10.1007/BF03404889 pubmed: 21714314 pmcid: 6974002
Chang P-H, Lai Y-H, Shun S-C, Lin LY, Chen ML, Yang Y, Tsai JC, Huang GS, Cheng SY (2008) Effects of a walking intervention on fatigue-related experiences of hospitalized acute myelogenous leukemia patients undergoing chemotherapy: a randomized controlled trial. J Pain Symptom Manag 35:524–534. https://doi.org/10.1016/j.jpainsymman.2007.06.013
doi: 10.1016/j.jpainsymman.2007.06.013
Gheyasi F, Baraz S, Malehi A et al (2019) Effect of the walking exercise program on cancer-related fatigue in patients with acute myeloid leukemia undergoing chemotherapy. Asian Pac J Cancer Prev 20:1661–1666. https://doi.org/10.31557/APJCP.2019.20.6.1661
doi: 10.31557/APJCP.2019.20.6.1661 pubmed: 31244285 pmcid: 7021614
Zhou Y, Zhu J, Gu Z, Yin X (2016) Efficacy of exercise interventions in patients with acute leukemia: a meta-analysis. PLoS One 11:e0159966. https://doi.org/10.1371/journal.pone.0159966
doi: 10.1371/journal.pone.0159966 pubmed: 27463234 pmcid: 4962985
Scharhag-Rosenberger F, Becker T, Streckmann F et al (2014) Studien zu körperlichem Training bei onkologischen Patienten: Empfehlungen zu den Erhebungsmethoden. Dtsch Z Sportmed 65:304–313.  https://www.germanjournalsportsmedicine.com/artikel-online/archiv-2014/heft-11/studien-zu-koerperlichem-training-bei-onkologischen-patienten-empfehlungen-zu-den-erhebungsmethoden/ . Accessed 4 Oct 2019
Story C, Bryant AL, Phillips B, Bailey C, Shields EW, Battaglini C (2016) Comparison of methods for determining aerobic exercise intensity using heart rate in acute leukemia patients prior to induction chemotherapy. Biol Res Nurs 18:432–438. https://doi.org/10.1177/1099800416633836
doi: 10.1177/1099800416633836 pubmed: 26933148 pmcid: 5835965
Kuehl R, Scharhag-Rosenberger F, Schommer K et al (2015) Exercise intensity classification in cancer patients undergoing allogeneic HCT. Med Sci Sports Exerc 47:889–895. https://doi.org/10.1249/MSS.0000000000000498
doi: 10.1249/MSS.0000000000000498 pubmed: 25202849
American College of Sports Medicne (2017) American College of Sports Medicine. ACSM’s guidelines for exercise testing and prescription, 10th edn. Lippincott Williams & Wilki, Philadelphia
Zimmer P, Oberste M, Bloch W, Schenk A, Joisten N, Hartig P, Wolf F, Baumann FT, Garthe A, Hallek M, Elter T (2016) Impact of aerobic exercise training during chemotherapy on cancer related cognitive impairments in patients suffering from acute myeloid leukemia or myelodysplastic syndrome - study protocol of a randomized placebo-controlled trial. Contemp Clin Trials 49:1–5. https://doi.org/10.1016/j.cct.2016.05.007
doi: 10.1016/j.cct.2016.05.007 pubmed: 27261170
Wahl P, Bloch W, Mester J (2009) Moderne Betrachtungsweisen des Laktats: Laktat ein überschätztes und zugleich über-schätztes Molekül. Schweizerische Zeitschrift für Sportmedizin und Sporttraumatologie 57:100–107
Borg GAV (1982) Psychophysical bases of perceived exertion. Med Sci Sports Exerc 14:377–381
pubmed: 7154893
Goodwin ML, Harris JE, Hernández A, Gladden LB (2007) Blood lactate measurements and analysis during exercise: a guide for clinicians. J Diabetes Sci Technol 1:558–569. https://doi.org/10.1177/193229680700100414
doi: 10.1177/193229680700100414 pubmed: 19885119 pmcid: 2769631
Kulandaivelan VS, Mukhopadhyay SK et al (2009) Effect of combined electrical stimulation as a recovery modality on selected physiological transients in adolescent judo players. J Exerc Sci Physiother 5:80–86
Schneider J, Schlüter K, Sprave T, Wiskemann J, Rosenberger F (2020) Exercise intensity prescription in cancer survivors: ventilatory and lactate thresholds are useful submaximal alternatives to VO(2peak). Support Care Cance 28:5521–5528. https://doi.org/10.1007/s00520-020-05407-y
doi: 10.1007/s00520-020-05407-y
Löllgen H, Erdmann E, Gitt A (2010) Ergometrie: Belastungsuntersuchungen in Klinik und Praxis, 3rd edn. Springer-Verlag Berlin Heidelberg, Berlin
doi: 10.1007/978-3-540-92730-3
Niebauer J (2015) Sportkardiologie. Springer Berlin Heidelberg, Berlin
doi: 10.1007/978-3-662-43711-7
Jarden M, Baadsgaard MT, Hovgaard DJ, Boesen E, Adamsen L (2009) A randomized trial on the effect of multimodal intervention on physical capacity, functional performance and quality of life in adult patients undergoing allogeneic SCT. Bone Marrow Transplant 43(9):725–737
doi: 10.1038/bmt.2009.27
Knols RH, de Bruin ED, Uebelhart D, Aufdemkampe G, Schanz U, Stenner-Liewen F, Hitz F, Taverna C, Aaronson NK (2011) Effects on an outpatient physical ecercise program on hematopoietic stem-cell transplantation recipients: a randomized clinical trial. Bone Marrow Transplant 46(9):1245–1255
doi: 10.1038/bmt.2010.288
Klepin HD, Danhauer SC, Tooze JA, Stott K, Daley K, Vishnevsky T, Powell BL, Mihalko SL (2010) Exercise for older adult inpatients with acute myelogenous leukemia : a pilot study. J Geriatr Oncol 2:11–17. https://doi.org/10.1016/j.jgo.2010.10.004
doi: 10.1016/j.jgo.2010.10.004
Battaglini CL, Hackney AC, Garcia R, Groff D, Evans E, Shea T (2009) The effects of an exercise program in leukemia patients. Integr Cancer Ther 8:130–138. https://doi.org/10.1177/1534735409334266
doi: 10.1177/1534735409334266 pubmed: 19679621
Alibhai SMH, O’Neill S, Fisher-Schlombs K, Breunis H, Brandwein JM, Timilshina N, Tomlinson GA, Klepin HD, Culos-Reed SN (2012) A clinical trial of supervised exercise for adult inpatients with acute myeloid leukemia (AML) undergoing induction chemotherapy. Leuk Res 36:1255–1261. https://doi.org/10.1016/j.leukres.2012.05.016
doi: 10.1016/j.leukres.2012.05.016 pubmed: 22726923 pmcid: 3767429
Baumann FT, Zimmer P, Finkenberg K, Hallek M, Bloch W, Elter T (2012) Influence of endurance exercise on the risk of pneumonia and fever in leukemia and lymphoma patients undergoing high dose chemotherapy. A pilot study. J Sports Sci Med 11:638–642
pubmed: 24150073 pmcid: 3763309
Elter T, Stipanov M, Heuser E, von Bergwelt-Baildon M, Bloch W, Hallek M, Baumann F (2009) Is physical exercise possible in patients with critical cytopenia undergoing intensive chemotherapy for acute leukaemia or aggressive lymphoma? Int J Hematol 90:199–204. https://doi.org/10.1007/s12185-009-0376-4
doi: 10.1007/s12185-009-0376-4 pubmed: 19629631
De Backer IC, Schep G, Hoogeveen A et al (2007) Exercise testing and training in a cancer rehabilitation program: the advantage of the steep ramp test. Arch Phys Med Rehabil 88:610–616. https://doi.org/10.1016/j.apmr.2007.02.013
doi: 10.1016/j.apmr.2007.02.013 pubmed: 17466730
Stuiver MM, Kampshoff CS, Persoon S, Groen W, van Mechelen W, Chinapaw MJM, Brug J, Nollet F, Kersten MJ, Schep G, Buffart LM (2017) Validation and refinement of prediction models to estimate exercise capacity in cancer survivors using the steep ramp test. Arch Phys Med Rehabil 98:2167–2173. https://doi.org/10.1016/j.apmr.2017.02.013
doi: 10.1016/j.apmr.2017.02.013 pubmed: 28322759
van Waart H, Stuiver MM, van Harten WH, Geleijn E, de Maaker-Berkhof M, Schrama J, Geenen MM, Meerum Terwogt JM, van den Heiligenberg SM, Hellendoorn-van Vreeswijk JAJH, Sonke GS, Aaronson NK (2018) Recruitment to and pilot results of the PACES randomized trial of physical exercise during adjuvant chemotherapy for colon cancer. Int J Color Dis 33:29–40. https://doi.org/10.1007/s00384-017-2921-6
doi: 10.1007/s00384-017-2921-6

Auteurs

Anja Großek (A)

Department of Molecular and Cellular Sports Medicine, Institute of Cardiovascular Research and Sports Medicine, German Sport University Cologne, Cologne, Germany.

Thomas Elter (T)

Department I of Internal Medicine, Center for Integrated Oncology Köln Bonn, University of Cologne, Cologne, Germany.

Max Oberste (M)

Department of Molecular and Cellular Sports Medicine, Institute of Cardiovascular Research and Sports Medicine, German Sport University Cologne, Cologne, Germany.

Florian Wolf (F)

Department of Molecular and Cellular Sports Medicine, Institute of Cardiovascular Research and Sports Medicine, German Sport University Cologne, Cologne, Germany.

Niklas Joisten (N)

Department of Molecular and Cellular Sports Medicine, Institute of Cardiovascular Research and Sports Medicine, German Sport University Cologne, Cologne, Germany.
Division for Performance and Health (Sport Medicine), Department of Sport and Sport Science, Technical University Dortmund, Otto-Hahn-Str. 3, 44227, Dortmund, Germany.

Philipp Hartig (P)

Department of Molecular and Cellular Sports Medicine, Institute of Cardiovascular Research and Sports Medicine, German Sport University Cologne, Cologne, Germany.

David Walzik (D)

Division for Performance and Health (Sport Medicine), Department of Sport and Sport Science, Technical University Dortmund, Otto-Hahn-Str. 3, 44227, Dortmund, Germany.

Friederike Rosenberger (F)

Working Group Exercise Oncology, Department of Medical Oncology, National Center for Tumor Diseases (NCT), Heidelberg University Hospital, Heidelberg, Germany.

David Kiesl (D)

University Clinic for Hematology and Internal Oncology, Kepler University Hospital, Linz, Austria.

Patrick Wahl (P)

Department of Molecular and Cellular Sports Medicine, Institute of Cardiovascular Research and Sports Medicine, German Sport University Cologne, Cologne, Germany.

Wilhelm Bloch (W)

Department of Molecular and Cellular Sports Medicine, Institute of Cardiovascular Research and Sports Medicine, German Sport University Cologne, Cologne, Germany.

Philipp Zimmer (P)

Division for Performance and Health (Sport Medicine), Department of Sport and Sport Science, Technical University Dortmund, Otto-Hahn-Str. 3, 44227, Dortmund, Germany. philipp.zimmer@tu-dortmund.de.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH